BUDESONIDE/ FORMOTEROL (Symbicort Turbohaler®)
Clinical Indication
Asthma & COPD
Comments
3rd Choice Dry Powder
Management of Asthma in Adults
Management of Asthma in Children aged 5-11 years
Management of Asthma in Children and Young People aged 12-17 years
LLR Adult Asthma Guideline (≥18 years) AIR and MART FAQ
The LLR COPD guidelines have been updated (June 2026) and ICS/LABA combinations are no longer routinely recommended as a treatment option. No NEW initiations. For patients established on this therapy, treatment should be reviewed on a case-by-case basis, taking into account clinical stability and patient preference. Ongoing prescribing should be in line with the updated COPD guidelines.
Date of classification
May 2026
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.